Tumor-infiltrating regulatory T cells as targets of cancer immunotherapy
Regulatory T cells (Tregs) are abundant in tumor tissues, raising a question of whether
immunosuppressive tumor-infiltrating Tregs (TI-Tregs) can be selectively depleted or …
immunosuppressive tumor-infiltrating Tregs (TI-Tregs) can be selectively depleted or …
Principles of regulatory T cell function
S Dikiy, AY Rudensky - Immunity, 2023 - cell.com
Regulatory T (Treg) cells represent a distinct lineage of cells of the adaptive immune system
indispensable for forestalling fatal autoimmune and inflammatory pathologies. The role of …
indispensable for forestalling fatal autoimmune and inflammatory pathologies. The role of …
CXCR3 expression in regulatory T cells drives interactions with type I dendritic cells in tumors to restrict CD8+ T cell antitumor immunity
MAM Ayala, TF Campbell, C Zhang, N Dahan… - Immunity, 2023 - cell.com
Infiltration of regulatory T (Treg) cells, an immunosuppressive population of CD4+ T cells,
into solid cancers represents a barrier to cancer immunotherapy. Chemokine receptors are …
into solid cancers represents a barrier to cancer immunotherapy. Chemokine receptors are …
Regulatory cells and the effect of cancer immunotherapy
M Iglesias-Escudero, N Arias-González… - Molecular cancer, 2023 - Springer
Several mechanisms and cell types are involved in the regulation of the immune response.
These include mostly regulatory T cells (Tregs), regulatory macrophages (Mregs), myeloid …
These include mostly regulatory T cells (Tregs), regulatory macrophages (Mregs), myeloid …
Neoadjuvant atezolizumab plus chemotherapy in gastric and gastroesophageal junction adenocarcinoma: the phase 2 PANDA trial
YL Verschoor, J van de Haar, JG van den Berg… - Nature medicine, 2024 - nature.com
Gastric and gastroesophageal junction (G/GEJ) cancers carry a poor prognosis, and despite
recent advancements, most patients die of their disease. Although immune checkpoint …
recent advancements, most patients die of their disease. Although immune checkpoint …
Therapeutic targeting of regulatory T cells in cancer
F Shan, A Somasundaram, TC Bruno, CJ Workman… - Trends in cancer, 2022 - cell.com
The success of immunotherapy in oncology underscores the vital role of the immune system
in cancer development. Regulatory T cells (Tregs) maintain a fine balance between …
in cancer development. Regulatory T cells (Tregs) maintain a fine balance between …
How chemokines organize the tumour microenvironment
For our immune system to contain or eliminate malignant solid tumours, both myeloid and
lymphoid haematopoietic cells must not only extravasate from the bloodstream into the …
lymphoid haematopoietic cells must not only extravasate from the bloodstream into the …
Advances in immunology and immunotherapy for mesenchymal gastrointestinal cancers
Mesenchymal gastrointestinal cancers are represented by the gastrointestinal stromal
tumors (GISTs) which occur throughout the whole gastrointestinal tract, and affect human …
tumors (GISTs) which occur throughout the whole gastrointestinal tract, and affect human …
Cytokines: can cancer get the message?
RM Morris, TO Mortimer, KL O'Neill - Cancers, 2022 - mdpi.com
Simple Summary Cytokines are important molecular players in cancer development,
progression, and potential targets for treatment. Despite being small and overlooked …
progression, and potential targets for treatment. Despite being small and overlooked …
Structural basis of antibody inhibition and chemokine activation of the human CC chemokine receptor 8
The CC motif chemokine receptor 8 (CCR8) is a class A G-protein coupled receptor that has
emerged as a promising therapeutic target in cancer. Targeting CCR8 with an antibody has …
emerged as a promising therapeutic target in cancer. Targeting CCR8 with an antibody has …